CJC-1295 (No DAC) 5MG + Ipamorelin 5MG Blend
· Lyophilised powder
Pre-blended CJC-1295 (no DAC) and Ipamorelin, 5 mg of each, for research applications.
CJC-1295 (NO DAC) 2MG is a high-purity lyophilized peptide intended exclusively for laboratory and scientific research use. CJC-1295 (No DAC), also known as Modified GRF (1-29), is a synthetic growth hormone-releasing hormone (GHRH) analog designed for short-duration activity. It has been extensively studied for its interaction with GHRH receptors and its effects on growth hormone secretion, endocrine signaling, and metabolic regulation.
Product Features
- Strength: 5 mg per vial
- Form: Lyophilized (freeze-dried) powder
- High-purity research-grade peptide
- Manufactured under strict quality control standards
- Sterile, securely sealed vial
Research Applications
CJC-1295 (No DAC) is commonly investigated in laboratory studies involving:
- Growth hormone secretion
- Growth hormone-releasing hormone (GHRH) receptor signaling
- Endocrine system regulation
- Insulin-like growth factor-1 (IGF-1) research
- Metabolic function
- Peptide pharmacology
- Compound
- CJC-1295 (No DAC) 5MG + Ipamorelin 5MG Blend
- Strength
- Form supplied
- Lyophilised powder
- Research areas
- Blends
- Storage
- Store lyophilised material refrigerated between 2–8°C (Celsius), cold and dark, protected from light and moisture.
- Batch reference
- Stated on the vial label at dispatch
- Analytical documentation
- No analytical document is currently held for this batch. Where documentation is held it is published here.
Specification
Research-use notice
All products supplied by The Peptide Kings are sold strictly for laboratory research use only. They are not medicines, not dietary supplements, and are not intended for human or veterinary consumption or administration. Information published on this website is provided for educational and scientific reference purposes only and must not be interpreted as medical advice.